Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 17 (IL-17), also known as IL-17A, is a pro-inflammatory cytokine and a member of the IL-17 family. It is primarily produced by Th17 cells and plays a central role in host defense against extracellular pathogens, inflammation, and bone metabolism. Dysregulated IL-17 signaling contributes to several chronic inflammatory and autoimmune diseases, making it a therapeutic target.
Monoclonal antibodies that neutralize IL-17A or block its receptor
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 17 (IL-17).